Discovery of a Biased Allosteric Modulator for Cannabinoid 1 Receptor: Preclinical Anti-Glaucoma Efficacy

We apply the magic methyl effect to improve the potency/efficacy of GAT211, the prototypic 2-phenylindole-based cannabinoid type-1 receptor (CB1R) agonist-positive allosteric modulator (ago-PAM). Introducing a methyl group at the a-position of nitro group generated two diastereomers, the greater pot...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medicinal chemistry Jg. 64; H. 12; S. 8104 - 8126
Hauptverfasser: Garai, Sumanta, Leo, Luciana M., Szczesniak, Anna-Maria, Hurst, Dow P., Schaffer, Peter C., Zagzoog, Ayat, Black, Tallan, Deschamps, Jeffrey R., Miess, Elke, Schulz, Stefan, Janero, David R., Straiker, Alex, Pertwee, Roger G., Abood, Mary E., Kelly, Melanie E. M., Reggio, Patricia H., Laprairie, Robert B., Thakur, Ganesh A.
Format: Journal Article
Sprache:Englisch
Veröffentlicht: WASHINGTON Amer Chemical Soc 24.06.2021
Schlagworte:
Allosteric Site
Animals
Cannabinoid Receptor Agonists - chemical synthesis
Cannabinoid Receptor Agonists - metabolism
Cannabinoid Receptor Agonists - therapeutic use
Chemistry, Medicinal
CHO Cells
Cricetulus
Glaucoma - drug therapy
HEK293 Cells
Hippocampus - cytology
Humans
Indoles - chemical synthesis
Indoles - metabolism
Indoles - therapeutic use
Intraocular Pressure - drug effects
Life Sciences & Biomedicine
Ligands
Male
Mice
Mice, Inbred C57BL
Molecular Conformation
Molecular Docking Simulation
Molecular Dynamics Simulation
Neurons - drug effects
Pharmacology & Pharmacy
Receptor, Cannabinoid, CB1 - agonists
Receptor, Cannabinoid, CB1 - chemistry
Receptor, Cannabinoid, CB1 - metabolism
Science & Technology
Stereoisomerism
Structure-Activity Relationship
CB1
DRUG DISCOVERY
ENDOCANNABINOID SYSTEM
PROTEIN-COUPLED RECEPTORS
FUNCTIONAL SELECTIVITY
GENERAL FORCE-FIELD
INTRAOCULAR-PRESSURE
BINDING
MU-OPIOID RECEPTOR
AGONIST
ISSN:0022-2623, 1520-4804, 1520-4804
Online-Zugang:Weitere Angaben
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:We apply the magic methyl effect to improve the potency/efficacy of GAT211, the prototypic 2-phenylindole-based cannabinoid type-1 receptor (CB1R) agonist-positive allosteric modulator (ago-PAM). Introducing a methyl group at the a-position of nitro group generated two diastereomers, the greater potency and efficacy of erythro, (+/-)-9 vs threo, (+/-)-10 constitutes the first demonstration of diastereoselective CB1R-allosteric modulator interaction. Of the (+/-)-9 enantiomers, (-)-(S,R)-13 evidenced improved potency over GAT211 as a CB1R ago-PAM, whereas (+)-(R,S)-14 was a CB1R allosteric agonist biased toward G protein- vs beta-arrestin1/2-dependent signaling. (-)-(S,R)-13 and (+)-(R,S)-14 were devoid of undesirable side effects (triad test), and (+)-(R,S)-14 reduced intraocular pressure with an unprecedentedly long duration of action in a murine glaucoma model. (-)-(S,R)-13 docked into both a CB1R extracellular PAM and intracellular allosteric-agonist site(s), whereas (+)-(R,S)-I4 preferentially engaged only the latter. Exploiting G-protein biased CB1R-allosteric modulation can offer safer therapeutic candidates for glaucoma and, potentially, other diseases.
Bibliographie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0022-2623
1520-4804
1520-4804
DOI:10.1021/acs.jmedchem.1c00040